Prognostic significance of BAG-1 expression in nonsmall cell lung cancer

International Journal of Cancer

Volumn 95, Issue 5, 2001, Pages 317-322

  Rorke, Stewart ^a   Murphy, Sean ^a   Khalifa, Mahmoud ^a   Chernenko, Garry ^a   Tang, Shou Ching ^a,b,c  

^a MEMORIAL UNIVERSITY OF NEWFOUNDLAND   (Canada)

^b Newfoundland Cancer Foundation   (Canada)

^c Newfoundland Cancer Treatment and Research Foundation   (Canada)

Author keywords

Apoptosis; BAG 1 RAP46; Lung cancer; Prognosis

Indexed keywords

BAG 1 PROTEIN; GENE PRODUCT; UNCLASSIFIED DRUG;

ADULT; AGE; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER MORTALITY; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; DIAGNOSTIC PROCEDURE; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; CARRIER PROTEINS; COHORT STUDIES; DNA-BINDING PROTEINS; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOHISTOCHEMISTRY; LOGISTIC MODELS; LUNG NEOPLASMS; MALE; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES; SUBCELLULAR FRACTIONS; SURVIVAL RATE; TRANSCRIPTION FACTORS;

EID: 0035922110     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/1097-0215(20010920)95:5<317::AID-IJC1055>3.0.CO;2-J     Document Type: Article

References (41)

1. Annual report to the nation on the status of cancer, 1973-1996, with a special section on lung cancer and tobacco smoking
2. Survival in early-stage non-small cell lung cancer
3. Adjuvant chemotherapy in non-small cell lung cancer
4. The molecular biology of lung cancer pathogenesis
5. Mutations in the p53 gene are frequent in primary resected non-small cell lung cancer
6. The prognostic significance of p53 and Bcl-2 expression in adenocarcinoma and its correlation with Ki-67 growth fraction
7. Nuclear p53 overexpression is an independent prognostic parameter in node-negative non-small cell lung carcinoma
8. Prognostic significance of the expression of ras oncogene product in non-small cell lung cancer
9. K-ras oncogene activation as a prognostic marker in adenocarcinoma of lung
10. Ras gene mutations in non-small cell lung cancers are associated with shortened survival irrespective of treatment intent
11. Expression of p53 oncoprotein in non-small cell lung cancer: A favorable prognostic factor
12. Expression of apoptosis regulatory proteins of the Bcl-2 family and p53 in primary resected non-small-cell lung cancer
13. Bcl-2 protein: A prognostic factor inversely correlated to p53 in non-small cell lung cancer
14. Bcl-2 and p53 protein expression in nonsmall cell lung cancers: Correlation with survival time
15. Bcl-2 oncoprotein in surgically resected non-small cell lung cancer: Possibly favorable prognostic factor in association with low association of distant metastasis
16. Bcl-2 protein and prognosis in patients with potentially curable non-small cell lung cancer
17. Absence of prognostic significance of Bcl-2 immunopositivity in non-small cell lung cancer: Analysis of 427 cases
18. The interactive effect of Ras, HER2, p53, and Bcl-2 expression in predicting the survival of nonsmall cell lung cancer patients
19. Bcl-2 immunohistochemistry in a surgical series of non-small cell lung cancer patients
20. Bcl-2 expression in non-small cell lung cancer: Higher frequency of expression in squamous cell carcinomas with earlier pT status
21. Resistance to apoptosis is correlated with the reduced caspase-3 activation and enhanced expression of anti-apoptotic proteins in human cervical multidrug-resistant cells
22. Differential expression of anti-apoptotic gene BAG-1 in human breast normal and cancer cell lines and tissues
23. Overexpression of anti-apoptotic gene BAG-1 in human cervical cancer
24. Cloning and functional analysis of Bag-1: A novel Bcl-2 binding protein with anti-cell death activity
25. Interaction of BAG-1 with retinoic acid receptor and its inhibition of retenoic acid-induced apoptosis in cancer cells
26. BAG-1 p50 isoform interacts with the vitamin D receptor and its cellular overexpression inhibits the vitamin D pathway
27. BAG-1 protein enhances androgen receptor function
28. HGF receptor associates with the anti-apoptotic protein BAG-1 and prevents cell death
29. BAG-1 modulates the chaperone activity of Hsp70/Hsc70
30. BAG-1 and Bcl-2 in IL-2 signaling
31. Cloning and characterization of the human BAG-1 gene promoter: Upregulation by tumor-derived p53 mutants
32. Human BAG-1/RAP46 protein is generated as four isoforms by alternative translation initiation and overexpressed in human cancer cells
33. Expression of Bag-1 in invasive breast cancer patients
34. An evolutionarily conserved family of Hsp70/Hsc70 molecular chaperone regulators
35. Expression and location of Hsp70/Hsc-binding anti-apoptotic protein BAG-1 and its variants in normal tissues and tumor cell lines
36. BAG-1: A novel biomarker predicting long-term survival in early-stage breast cancer
37. Mutation and expression analyses reveal differential subcellular compartmentalization of PTEN in endocrine pancreatic tumors compared to normal islet cells
38. Differential nuclear and cytoplasmic expression of PTEN in normal thyroid tissue, and benign and malignant epithelial thyroid tumors
39. Enhanced apoptosis predicts shortened survival in non-small cell lung carcinoma
40. Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells